Pluri Inc   (PLUR)
Other Ticker:  
Price: $0.7360 $-0.01 -1.538%
Day's High: $0.782 Week Perf: -5.64 %
Day's Low: $ 0.72 30 Day Perf: -4.79 %
Volume (M): 51 52 Wk High: $ 1.09
Volume (M$): $ 37 52 Wk Avg: $0.73
Open: $0.73 52 Wk Low: $0.43

 Market Capitalization (Millions $) 31
 Shares Outstanding (Millions) 42
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -24
 Cash Flow (TTM) (Millions $) -5
 Capital Exp. (TTM) (Millions $) 0

Pluri Inc
Pluri Inc is a software development company that specializes in creating innovative and customizable solutions for businesses. They offer a wide range of services including software development, web development, mobile app development, and cloud solutions. Pluri Inc is known for its expertise in utilizing advanced technologies like artificial intelligence (AI), blockchain, and internet of things (IoT) to help businesses streamline their operations and enhance their productivity. With a highly skilled team of developers, Pluri Inc is committed to creating cutting-edge software solutions that meet the unique needs of their clients. Overall, Pluri Inc aims to empower businesses with advanced technological tools and provide them with the competitive edge they need in today's rapidly evolving digital landscape.

   Company Address: MATAM Advanced Technology Park Haifa 3508409
   Company Phone Number: 74-7108600   Stock Exchange / Ticker: NASDAQ PLUR


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Pluri Inc

Pluri Inc.'s Groundbreaking Cell-Based Coffee Production Shatters Financial Expectations with 94.444% Revenue Improvement, Amidst $-0.12 per Share Loss

As a biotech enthusiast and a coffee lover, I have always been fascinated by the intersection of sustainability and global well-being. Pluri Inc.'s recent announcement of their cell-based coffee production is not only a groundbreaking solution to combat the coffee crisis but also an impressive achievement in the financial sphere. With their extraordinary revenue improvement and stock market performance, Pluri Inc. has proven itself to be a force to be reckoned with.
In the financial three months closing on December 31, 2023, Pluri Inc. announced a remarkable revenue improvement of 94.444% year on year, bringing their revenue up to $0.11 million. However, the company also reported a loss of $-0.12 per share. Although this may seem concerning at first glance, it is crucial to analyze the context and historical performance.

Product Service News

From Lab to Cup: Pluri Inc. Brewing a Sustainable and Flavorful Coffee Revolution

Published Tue, Jan 23 2024 7:00 AM UTC

Step into the Future: Pluri Inc. Introduces Cell-Based Coffee to Combat the Global Coffee CrisisHAIFA, Israel, Jan. 23, 2024 - Pluri Inc., a prominent biotech company dedicated to promoting global well-being and sustainability, has recently unveiled its groundbreaking cell-based coffee production. This innovative product has the potential to revolutionize the traditional cof...

Licensing Agreement

Uniting Cells and Innovation: Pluri and Bar-Ilan University Collaborate in Revolutionary Treatment for Cocaine Addiction

Published Thu, Dec 21 2023 12:00 PM UTC

Pluri and Bar-Ilan University Collaborate to Develop Groundbreaking Treatment for Cocaine AddictionHAIFA, Israel - In an exciting development for the biomedical field, Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR), a renowned biotech company focused on cellular therapeutics, has recently entered into an agreement with BIRAD Research & Development Company Ltd., the commercial arm of...

Pluri Inc

Breaking News: Pluri Inc's Remarkable Turnaround: Deficit Transformed into Profit during Q1 2024 Earnings Season!

The first quarter of 2024 earnings season brought mixed results for Pluri Inc. While the company managed to reduce its loss per share and reported a net loss lower than the previous year, its revenue witnessed a significant decline. Despite the turbulent financials, Pluri Inc's stock has recently experienced a noteworthy gain.
Financial Results:
Pluri Inc showcased positive signs in terms of its earnings per share (EPS) for the first quarter of 2024. The company decreased its loss per share to -$0.12, a notable improvement compared to the -$0.19 per share reported a year ago. Furthermore, Pluri Inc's EPS improved from -$0.18 per share from the previous financial reporting period.

Pluri Inc

Pluri Inc Faces Investor Concerns as Shares Plummet and Disappointing Financial Results Emerge

Pluri Inc, a biotechnology and pharmaceutical company, has recently witnessed a decline in its shares and reported disappointing financial results for the fiscal year closing June 30, 2023. This article will analyze the implications of these results and examine the potential impact on the company in the future.
Decreasing Share Performance:
Over the past week, Pluri Inc's shares experienced a decline of -6.25%, reaching their 52-week low. When considering the year to date performance, the shares have suffered a significant decrease of -41.16%. These figures signal a bearish sentiment among investors and raise concerns about the future prospects of the company.


Pluri Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com